Skip to main content
    A

    Anbio Biotechnology Class A Ordinary Shares (NNNN)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.89
    +0.30 (+8.36%)

    Market Cap: $157.57M

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 26
    Reported Jul 7
    		$N/AN/A-N/ABeat---
    Sep 25
    Reported Dec 30
    		$0.09$0.00-N/ABeat---
    Mar 25
    Reported Apr 28
    		$-0.03$0.00-N/AMiss---
    Sep 24
    Reported Dec 31
    		$0.09$0.00-N/ABeat---

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF139.95xFCF Yield0.71%
    Profitability
    Profit Margin74.10%Operating Margin59.10%
    ROE27.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio344.31xQuick Ratio344.31x
    Trading Statistics
    BetaN/AAvg Volume51.22K
    52-Week High$44.7352-Week Low$3.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.66
    SMA 20$3.67
    SMA 50$5.07
    SMA 200$16.62
    EMA 10$3.70
    EMA 20$3.94
    EMA 50$5.43
    EMA 200$14.07

    MACD

    Line: -0.44Signal: -0.57Hist: 0.13

    ADX

    ADX: 28.1+DI: 16.5-DI: 21.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down36.0
    PSAR$3.18

    Bollinger Bands

    Upper Band$4.28
    Lower Band$3.07
    %B Position3293%(Upper)
    Band Width0.68

    RSI (14-Day)

    Neutral
    43.5

    Momentum Oscillators

    Stoch %K49.7
    Stoch %D45.4
    Williams %R-38.5
    ROC (10d)2.1%
    Momentum0.08
    CCI (20d)44.5
    MFI (14d)61.6

    Volatility Measures

    ATR (14d)$0.47(12.0%)
    StdDev (20d)0.30
    Hist Vol105.2%(High)

    Volume Flow

    VWAP$3.82
    OBV994.3K
    AD Line-1.7M
    CMF (20d)-0.192

    Volume Metrics

    Avg Vol (20d)51.1K
    Vol Ratio0.6x
    VWMA (20d)$3.66

    Pivot Points

    R3$4.02
    R2$3.85
    R1$3.72
    Pivot Point$3.55
    S1$3.42
    S2$3.25
    S3$3.12

    Advanced Oscillators

    TSI-31.60
    Ultimate Osc46.4
    KST-273.94

    Financial Data

    QuarterMar 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$4.74M$2.03M$5.01M$-3,129,086$2.53M$1.17M$6.32M$2.92M$3.95M$1.83M$3.31M$1.53M
    Cost of Revenue$876,722$375,871$384,382$175,970$390,512$180,374$2.10M$969,507$2.26M$1.04M$1.36M$631,277
    Gross Profit$3.86M$1.66M$4.62M$-2,595,792$2.14M$987,382$4.23M$1.96M$1.69M$781,924$1.94M$898,511
    Operating Expenses$1.06M$454,997$945,209$-686,064$3.87M$1.79M$337,502$156,127$1.11M$512,082$406,055$187,887
    R&D$81,637$35,000$143,409$65,653$353,467$163,264$138,025$63,850$145,696$67,350$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating Income$2.80M$1.20M$3.68M$-1,909,728$-1,735,255$-801,499$3.89M$1.80M$583,740$269,841$1.54M$710,624
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$176,338$0$0$1,861$861$0$0$0$0
    Income Before Tax$3.04M$1.30M$4.15M$-2,086,066$-1,324,772$-611,901$3.89M$1.80M$792,932$366,542$1.64M$760,313
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$3.04M$1.30M$4.15M$-2,086,066$-1,324,772$-611,901$3.89M$1.80M$792,932$366,542$1.64M$760,313
    EBITDA$2.80MN/A$3.68MN/A$-1,324,776N/A$3.89MN/A$796,474N/AN/AN/A
    EBITN/AN/AN/AN/A$-1,735,255N/A$3.89MN/AN/AN/A$1.54MN/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NNNN

    News

    No news available

    Company news will appear here when available

    NNNN Valuation and Fair Value

    P/FCF
    140.0x
    P/B
    5.7x
    See GNG's fair value

    NNNN Profitability: Margins, ROIC and FCF

    Gross margin
    87.2%
    Operating margin
    59.1%
    Net margin
    74.1%
    ROE
    27.1%
    FCF margin
    14.1%
    FCF yield
    0.7%

    NNNN Competitors

    CompanyTicker
    Quipt Home Medical CorpQIPT
    Innate PharmaIPHA
    Oramed Pharmaceuticals IncORMP
    Sutro BiopharmaSTRO
    AN2 Therapeutics IncANTX
    Inovio Pharmaceuticals IncINO
    EDAP TMS SAEDAP
    Mersana Therapeutics IncMRSN

    Sector: Healthcare

    NNNN Bull Case vs Bear Case

    Bull case

    • NNNN has a 74.1% net profit margin.
    • NNNN grew quarterly revenue 73.9% year over year.

    Frequently Asked Questions About NNNN

    Does NNNN pay dividends?

    Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay a regular dividend.

    What is NNNN's market cap?

    Anbio Biotechnology Class A Ordinary Shares (NNNN) has a market capitalization of $157.57M with a current stock price of $3.89.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In